Spring Universal Infusion Sets utilize the company’s proprietary spring-based delivery technology with a Detach-Detect mechanism to deliver insulin into patient’s body.

The Spring Universal features hidden, auto-retractable needle, 360 degree connector, and smallest one-click, all-in-one inserter.

In case the base of the infusion set detaches from the user’s body, a blocking mechanism is triggered which, in turn, creates an occlusion.

This evokes an occlusion alarm in an insulin pump.

This feature enables for continuously controlled and monitored insulin delivery, providing additional safety.

D Medical CEO Efri Argaman said this marks their third non-exclusive distribution agreement and provides them with important new access to the governmental sector.